These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 21475005)
1. Positron emission tomography/computed tomographic scans compared to computed tomographic scans for detecting colorectal liver metastases: a systematic review. Patel S; McCall M; Ohinmaa A; Bigam D; Dryden DM Ann Surg; 2011 Apr; 253(4):666-71. PubMed ID: 21475005 [TBL] [Abstract][Full Text] [Related]
2. Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver? Selzner M; Hany TF; Wildbrett P; McCormack L; Kadry Z; Clavien PA Ann Surg; 2004 Dec; 240(6):1027-34; discussion 1035-6. PubMed ID: 15570208 [TBL] [Abstract][Full Text] [Related]
3. Improved long-term survival after resection of colorectal liver metastases following staging with FDG positron emission tomography. Abbadi RA; Sadat U; Jah A; Praseedom RK; Jamieson NV; Cheow HK; Whitley S; Ford HE; Wilson CB; Harper SJ; Huguet EL J Surg Oncol; 2014 Sep; 110(3):313-9. PubMed ID: 24737685 [TBL] [Abstract][Full Text] [Related]
4. The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases. Wiering B; Krabbe PF; Jager GJ; Oyen WJ; Ruers TJ Cancer; 2005 Dec; 104(12):2658-70. PubMed ID: 16315241 [TBL] [Abstract][Full Text] [Related]
5. The role and limitations of 18-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) scan and computerized tomography (CT) in restaging patients with hepatic colorectal metastases following neoadjuvant chemotherapy: comparison with operative and pathological findings. Lubezky N; Metser U; Geva R; Nakache R; Shmueli E; Klausner JM; Even-Sapir E; Figer A; Ben-Haim M J Gastrointest Surg; 2007 Apr; 11(4):472-8. PubMed ID: 17436132 [TBL] [Abstract][Full Text] [Related]
6. Controversies in the management of colorectal liver metastases: role of PET and PET/CT. Wiering B; Vogel WV; Ruers TJ; Oyen WJ Dig Surg; 2008; 25(6):413-20. PubMed ID: 19212113 [TBL] [Abstract][Full Text] [Related]
7. Effect of PET before liver resection on surgical management for colorectal adenocarcinoma metastases: a randomized clinical trial. Moulton CA; Gu CS; Law CH; Tandan VR; Hart R; Quan D; Fairfull Smith RJ; Jalink DW; Husien M; Serrano PE; Hendler AL; Haider MA; Ruo L; Gulenchyn KY; Finch T; Julian JA; Levine MN; Gallinger S JAMA; 2014 May; 311(18):1863-9. PubMed ID: 24825641 [TBL] [Abstract][Full Text] [Related]
8. Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases. Seo HJ; Kim MJ; Lee JD; Chung WS; Kim YE Invest Radiol; 2011 Sep; 46(9):548-55. PubMed ID: 21577131 [TBL] [Abstract][Full Text] [Related]
9. Clinical impact of fluorodeoxyglucose-positron emission tomography scan/computed tomography in comparison with computed tomography on the detection of colorectal cancer recurrence. Deleau C; Buecher B; Rousseau C; Kraeber-Bodéré F; Flamant M; des Varannes SB; Frampas E; Galmiche JP; Matysiak-Budnik T Eur J Gastroenterol Hepatol; 2011 Mar; 23(3):275-81. PubMed ID: 21304319 [TBL] [Abstract][Full Text] [Related]
10. Comparison of multiphase CT, FDG-PET and intra-operative ultrasound in patients with colorectal liver metastases selected for surgery. Wiering B; Ruers TJ; Krabbe PF; Dekker HM; Oyen WJ Ann Surg Oncol; 2007 Feb; 14(2):818-26. PubMed ID: 17136470 [TBL] [Abstract][Full Text] [Related]
11. The impact of 18F-FDG PET/CT in patients with liver metastases. Chua SC; Groves AM; Kayani I; Menezes L; Gacinovic S; Du Y; Bomanji JB; Ell PJ Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):1906-14. PubMed ID: 17713766 [TBL] [Abstract][Full Text] [Related]
12. Intraoperative sonography in patients with colorectal cancer and resectable liver metastases on preoperative FDG-PET-CT. Wildi SM; Gubler C; Hany T; Petrowsky H; Clavien PA; Jochum W; Gerlach T; Fried M; Mullhaupt B J Clin Ultrasound; 2008 Jan; 36(1):20-6. PubMed ID: 17937421 [TBL] [Abstract][Full Text] [Related]
13. A meta-analysis exploring the role of PET and PET-CT in the management of potentially resectable colorectal cancer liver metastases. Daza JF; Solis NM; Parpia S; Gallinger S; Moulton CA; Belley-Cote EP; Levine MN; Serrano PE Eur J Surg Oncol; 2019 Aug; 45(8):1341-1348. PubMed ID: 30928334 [TBL] [Abstract][Full Text] [Related]
14. Detection of colo-rectal liver metastases: prospective comparison of contrast enhanced US, multidetector CT, PET/CT, and 1.5 Tesla MR with extracellular and reticulo-endothelial cell specific contrast agents. Mainenti PP; Mancini M; Mainolfi C; Camera L; Maurea S; Manchia A; Tanga M; Persico F; Addeo P; D'Antonio D; Speranza A; Bucci L; Persico G; Pace L; Salvatore M Abdom Imaging; 2010 Oct; 35(5):511-21. PubMed ID: 19562412 [TBL] [Abstract][Full Text] [Related]
15. Comparing respiratory gated with delayed scans in the detection of colorectal carcinoma hepatic and pulmonary metastases with 18F-FDG PET-CT. Hassler S; Hubele F; Constantinesco A; Goetz C Clin Nucl Med; 2014 Jan; 39(1):e7-e13. PubMed ID: 23751828 [TBL] [Abstract][Full Text] [Related]
16. The use of FDG-positron emission tomography for the evaluation of colorectal metastases of the liver. Boykin KN; Zibari GB; Lilien DL; McMillan RW; Aultman DF; McDonald JC Am Surg; 1999 Dec; 65(12):1183-5. PubMed ID: 10597072 [TBL] [Abstract][Full Text] [Related]
17. PET imaging for evaluation of metastatic colorectal cancer of the liver. Erturk SM; Ichikawa T; Fujii H; Yasuda S; Ros PR Eur J Radiol; 2006 May; 58(2):229-35. PubMed ID: 16457980 [TBL] [Abstract][Full Text] [Related]
18. The impact of PET/CT on the management of hepatic and extra hepatic metastases from gastrointestinal cancers. Polat E; Bostanci EB; Aksoy E; Karaman K; Poyraz NY; Duman U; Gencturk ZB; Yol S Eur J Radiol; 2015 Jun; 84(6):1165-70. PubMed ID: 25814398 [TBL] [Abstract][Full Text] [Related]